栄研化学の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2025/08/13 | 2,367 | 2,393 | 2,341 | 2,379 | -1 | ±0% | 93,300 |
2025/08/12 | 2,359 | 2,388 | 2,320 | 2,380 | +63 | +2.7% | 138,400 |
2025/08/08 | 2,288 | 2,325 | 2,278 | 2,317 | +55 | +2.4% | 109,900 |
2025/08/07 | 2,230 | 2,276 | 2,229 | 2,262 | +31 | +1.4% | 89,700 |
2025/08/06 | 2,252 | 2,256 | 2,225 | 2,231 | -24 | -1.1% | 77,900 |
2025/08/05 | 2,245 | 2,295 | 2,239 | 2,255 | +10 | +0.4% | 99,700 |
2025/08/04 | 2,217 | 2,256 | 2,205 | 2,245 | +9 | +0.4% | 140,000 |
2025/08/01 | 2,394 | 2,430 | 2,205 | 2,236 | -153 | -6.4% | 348,700 |
2025/07/31 | 2,380 | 2,395 | 2,344 | 2,389 | +24 | +1% | 154,100 |
2025/07/30 | 2,350 | 2,375 | 2,330 | 2,365 | +19 | +0.8% | 106,100 |
2025/07/29 | 2,282 | 2,346 | 2,282 | 2,346 | +51 | +2.2% | 141,100 |
2025/07/28 | 2,267 | 2,323 | 2,251 | 2,295 | +39 | +1.7% | 122,700 |
2025/07/25 | 2,221 | 2,265 | 2,210 | 2,256 | +37 | +1.7% | 69,000 |
2025/07/24 | 2,170 | 2,221 | 2,165 | 2,219 | +67 | +3.1% | 101,300 |
2025/07/23 | 2,117 | 2,176 | 2,113 | 2,152 | +43 | +2% | 121,300 |
2025/07/22 | 2,121 | 2,140 | 2,102 | 2,109 | -27 | -1.3% | 66,700 |
2025/07/18 | 2,119 | 2,169 | 2,119 | 2,136 | +36 | +1.7% | 112,000 |
2025/07/17 | 2,050 | 2,104 | 2,042 | 2,100 | +51 | +2.5% | 69,000 |
2025/07/16 | 2,030 | 2,056 | 2,013 | 2,049 | +6 | +0.3% | 98,500 |
2025/07/15 | 2,050 | 2,065 | 2,036 | 2,043 | +15 | +0.7% | 84,200 |
2025/07/14 | 2,024 | 2,034 | 2,011 | 2,028 | -4 | -0.2% | 87,500 |
2025/07/11 | 2,045 | 2,059 | 2,024 | 2,032 | -5 | -0.2% | 111,700 |
2025/07/10 | 2,071 | 2,071 | 2,036 | 2,037 | -41 | -2% | 118,300 |
2025/07/09 | 2,100 | 2,112 | 2,071 | 2,078 | -6 | -0.3% | 115,100 |
2025/07/08 | 2,087 | 2,104 | 2,074 | 2,084 | +9 | +0.4% | 99,100 |
2025/07/07 | 2,089 | 2,099 | 2,071 | 2,075 | -5 | -0.2% | 81,700 |
2025/07/04 | 2,101 | 2,104 | 2,061 | 2,080 | -20 | -1% | 59,400 |
2025/07/03 | 2,123 | 2,123 | 2,072 | 2,100 | -28 | -1.3% | 116,300 |
2025/07/02 | 2,120 | 2,143 | 2,113 | 2,128 | +13 | +0.6% | 88,800 |
2025/07/01 | 2,131 | 2,131 | 2,097 | 2,115 | -16 | -0.8% | 79,300 |
2025/06/30 | 2,151 | 2,152 | 2,126 | 2,131 | -2 | -0.1% | 109,300 |
2025/06/27 | 2,124 | 2,150 | 2,115 | 2,133 | +17 | +0.8% | 105,500 |
2025/06/26 | 2,148 | 2,154 | 2,103 | 2,116 | -40 | -1.9% | 107,300 |
2025/06/25 | 2,169 | 2,202 | 2,127 | 2,156 | +32 | +1.5% | 227,600 |
2025/06/24 | 2,154 | 2,158 | 2,106 | 2,124 | -6 | -0.3% | 94,400 |
2025/06/23 | 2,074 | 2,133 | 2,061 | 2,130 | +57 | +2.7% | 117,200 |
2025/06/20 | 2,108 | 2,111 | 2,073 | 2,073 | -38 | -1.8% | 140,100 |
2025/06/19 | 2,114 | 2,135 | 2,105 | 2,111 | +1 | ±0% | 63,300 |
2025/06/18 | 2,124 | 2,138 | 2,102 | 2,110 | -19 | -0.9% | 151,700 |
2025/06/17 | 2,179 | 2,187 | 2,128 | 2,129 | -71 | -3.2% | 136,800 |
2025/06/16 | 2,172 | 2,213 | 2,170 | 2,200 | +44 | +2% | 173,400 |
2025/06/13 | 2,190 | 2,203 | 2,146 | 2,156 | -7 | -0.3% | 266,500 |
2025/06/12 | 2,092 | 2,170 | 2,092 | 2,163 | +60 | +2.9% | 99,400 |
2025/06/11 | 2,026 | 2,110 | 2,015 | 2,103 | +68 | +3.3% | 117,300 |
2025/06/10 | 2,026 | 2,046 | 2,025 | 2,035 | +5 | +0.2% | 76,000 |
2025/06/09 | 2,015 | 2,036 | 2,011 | 2,030 | +10 | +0.5% | 67,400 |
2025/06/06 | 2,019 | 2,024 | 2,002 | 2,020 | +8 | +0.4% | 70,200 |
2025/06/05 | 2,002 | 2,036 | 1,994 | 2,012 | -3 | -0.1% | 83,000 |
2025/06/04 | 2,001 | 2,029 | 2,001 | 2,015 | +29 | +1.5% | 87,300 |
2025/06/03 | 1,998 | 2,000 | 1,972 | 1,986 | -15 | -0.7% | 99,100 |
1~
50
件表示中 / 7015件
類似銘柄と比較する
現在ご覧いただいている「栄研化」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
栄研化 | 237,900円 | +4.1% | -3.1% | 2.44% | 20.67倍 | 1.80倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
ゼリア新薬 | 203,200円 | +3.1% | -6.5% | 2.36% | 9.43倍 | 1.00倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
杏林製薬 | 156,600円 | -2.4% | -52.3% | 3.64% | 18.74倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
ネクセラファーマ | 93,600円 | +20.3% | - | 0.00% | 165.96倍 | 1.29倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
JCRファーマ | 63,300円 | +14.3% | - | 3.16% | 25.73倍 | 1.64倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
市場注目の銘柄
チャート関連のコラム